Facebook
Linkedin
Twitter
Industries
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Quick Byte
Resources
Search
Wednesday, September 10, 2025
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
ReadMagazine
Industries
All
Aerospace
Agritech
Automotive
BFSI
Biotechnology
Chemicals
Defence Technology
Energy, Power and Sustainability
Food & Beverage
Healthcare
Information Technology
MarTech
Internet Of Things (IOT)
Logistics and Supply Chain
Materials
Medical Devices
Retail
Semiconductor & Electronics
Smart Lighting
Servier Acquire Kaerus Bioscience for Fragile X Syndrome Treatment
Eaton and Xendee Partner on AI-Powered Microgrid Optimization Energy and Sustainability
EchoStar Announces Spectrum Sale and SpaceX Agreement
Leidos Australia unveils new Uncrewed Surface Vessel for Maritime Autonomy
Latest News
Interviews
Insights
Guest Post
Staff Writer
Featured Article
Quick Byte
Resources
Home
Tags
Kaerus Bioscience
Kaerus Bioscience
Biotechnology
Servier Acquire Kaerus Bioscience for Fragile X Syndrome Treatment
News Desk
-
September 9, 2025
Servier has entered into a definitive agreement with Kaerus Bioscience to acquire KER-0193, a potential first-in-disease treatment for Fragile X syndrome (FXS), the leading...
0
Fans
Like
3,912
Followers
Follow
0
Subscribers
Subscribe
Hot Topics
Servier Acquire Kaerus Bioscience for Fragile X Syndrome Treatment
Eaton and Xendee Partner on AI-Powered Microgrid Optimization Energy and Sustainability
EchoStar Announces Spectrum Sale and SpaceX Agreement
Load more
